Angiogenesis is not mediated by prostate cancer neuropeptides

Angiogenesis

Volumn 6, Issue 4, 2003, Pages 289-293

  Busby, J E ^a   Shih, S J ^a   Yang, J C ^a   Kung, H J ^a   Evans, C P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Endothelial cell; Neuroendocrine; Neuropeptides; Neurotrophins; Non receptor tyrosine kinases; Prostate cancer; Signal transduction

Indexed keywords

BOMBESIN; NEUROPEPTIDE; NEUROTENSIN; PROTEIN SAM68; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

BLOTTING, WESTERN; BOMBESIN; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEUROPEPTIDES; NEUROTENSIN; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; TIME FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3343013164     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:AGEN.0000029409.94626.64     Document Type: Article

References (34)

1. Cohen RJ, Glezerson G, Haffejee Z. Neuro-endocrine cells - a new prognostic parameter in prostate cancer. Br J Urol 1991; 68: 258-62.
2. di Sant'Agnese PA, Cockett AT. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996; 78: 357-61.
3. Noordzij MA, van Weerden WM, de Ridder CM et al. Neuro-endocrine differentiation in human prostatic tumor models. Am J Pathol 1996; 149: 859-71.
4. Cox ME, Deeble PD, Bissonette EA, Parsons SJ. Activated 3′,5′-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line. J Biol Chem 2000; 275: 13812-8.
5. Cox ME, Deeble PD, Lakhani S, Parsons SJ. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression. Cancer Res 1999; 59: 3821-30.
6. Bang YJ, Pirnia F, Fang WG et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 1994; 91: 5330-4.
7. Abrahamsson PA, Lilja H, Falkmer S, Wadstrom LB. Immuno-histochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 1988; 12: 39-46.
8. Bonkhoff H, Stein U, Remberger K. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 1995; 26: 167-70.
9. Bonkhoff H, Wernert N, Dhom G, Remberger K. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate 1991; 19: 91-8.
10. Kadmon D, Thompson TC, Lynch GR, Scardino PT. Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol 1991; 146: 358-61.
11. Dalsgaard CJ, Hultgardh-Nilsson A, Haegerstrand A, Nilsson J. Neuropeptides as growth factors. Possible roles in human diseases. Regul Pept 1989; 25: 1-9.
12. Iwamura M, Abrahamsson PA, Foss KA et al. Parathyroid hormone-related protein: A potential autocrine growth regulator in human prostate cancer cell lines. Urology 1994; 43: 675-9.
13. Seuwen K, Pouyssegur J. Serotonin as a growth factor. Biochem Pharmacol 1990; 39: 985-90.
14. Willey JC, Lechner JF, Harris CC. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 1984; 153: 245-8.
15. Yang JC, Novotny MJ, Kung H-J, Evans CP. Introduction of neuroendocrine differentiation contributes to prostate cancer progression in an androgen-independent environment. Proceedings of the American Association for Cancer Research 2002; 43: 231.
16. Lee LF, Guan J, Qiu Y, Kung HJ. Neuropeptide-induced androgen independence in prostate cancer cells: Roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 2001; 21: 8385-97.
17. Rozengurt E. Neuropeptides as cellular growth factors: Role of multiple signalling pathways. Eur J Clin Invest 1991; 21: 123-34.
18. Woll PJ. Neuropeptide growth factors and cancer. Br J Cancer 1991; 63: 469-75.
19. Borre M, Nerstrom B, Overgaard J. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. Clin Cancer Res 2000; 6: 1882-90.
20. Shih S-J, Dall'Era MA, Westphal HR et al. Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue. Prostate Cancer Prostat Dis 2003; 6: 131-37.
21. Dall'Era M, Shih S-J, Yang JC et al. Differential expresssion of angiogenic cytokines by cell lines and primary cultures of human prostate cancer. Prostate Cancer Prostat Dis 2001; 4: 106-11.
22. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 1994; 371: 168-70.
23. Rozengurt E. Early signals in the mitogenic response. Science 1986; 234: 161-6.
24. Sunday ME, Kaplan LM, Motoyama E et al. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 1988; 59: 5-24.
25. Hellmich MR, Ives KL, Udupi V et al. Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion. J Biol Chem 1999; 274: 23901-9.
26. Short SM, Talbott GA, Juliano RL. Integrin-mediated signaling events in human endothelial cells. Mol Biol Cell 1998; 9: 1969-80.
27. Qiu Y, Robinson D, Pretlow TG, Kung HJ. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci USA 1998; 95: 3644-9.
28. Tamagnone L, Lahtinen I, Mustonen T et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994; 9: 3683-8.
29. Chen R, Kim O, Li M et al. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Natl Cell Biol 2001; 3: 439-44.
30. Vigne P, Feolde E, Van Renterghem C et al. Properties and functions of a neuromedin-B-preferring bombesin receptor in brain microvascular endothelial cells. Eur J Biochem 1995; 233: 414-8.
31. Marion-Audibert AM, Nejjari M, Pourreyron C et al. Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells. Gastroenterol Clin Biol 2000; 24: 644-8.
32. Evans CP, Walsh DS, Kohn EC. An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1. Int J Cancer 1991; 49: 109-13.
33. Kahler CM, Kirchmair R, Kaufmann G et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler Thromb Vase Biol 1997; 17: 932-9.
34. Wiedermann CJ, Auer B, Sitte B et al. Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol 1996; 298: 335-8.